MedWatch

CHMP recommends approval of Pfizer's Covid-19 pill

Pfizer has received a positive opinion on its tablet treatment for Covid-19, Paxlovid, from the EMA’s expert committee. The pill was already in use in some countries, as the EMA had previously issued advice for emergency use of the unauthorized drug.

Photo: PFIZER/VIA REUTERS / X80001

The European Medicines Agency’s (EMA) expert committee, the CHMP, has recommended that Pfizer’s Paxlovid, a treatment for Covid-19, be approved in the EU.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs